Frantzi M, Latosinska A, Flühe L, Hupe MC, Critselis E, Kramer MW, Merseburger AS, Mischak H, Vlahou A.
Developing proteomic biomarkers for bladder cancer: towards clinical application.
Nat Rev Urol. 2015 Jun;12(6):317-30

 

Frantzi M, Zoidakis J, Papadopoulos T, Zürbig P, Katafigiotis I, Stravodimos K, Lazaris A, Giannopoulou I, Ploumidis A, Mischak H, Mullen W, Vlahou A.
IMAC fractionation in combination with LC-MS reveals H2B and NIF-1 peptides as potential bladder cancer biomarkers.
J Proteome Res. 2013 Sep 6; 12(9):3969-79.

 

Frantzi M, Metzger J, Banks RE, Husi H, Klein J, Dakna M, Mullen W, Cartledge JJ, Schanstra JP, Brand K, Kuczyk MA, Mischak H, Vlahou A, Theodorescu D, Merseburger AS.
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma.
J Proteomics. 2014 Feb 26;98:44-58.

 

Latosinska A, Frantzi M, Vlahou A, Mischak H.
Clinical applications of capillary electrophoresis coupled to mass spectrometry in biomarker discovery: Focus on Bladder Cancer.
Proteomics Clin Appl. 2013 Aug 23; 11:779-93.

 

Maria Frantzi, Akshay Bhat, Agnieszka Latosinska.
Clinical proteomic biomarkers: relevant issues on study design & technical considerations in biomarker development.
Clin Transl Med. 2014 Mar 29; 3(1):7.

 

Latosinska A, Frantzi M, Mullen W, Vlahou A, Makridakis M.
Targeting the proteome of cellular fractions: focus on secreted proteins.
Methods Mol Biol. 2015;1243:29-41.


Akshay Bhat, Mohammed Dakna and Harald Mischak. 
Integrating Proteomics Profiling Data Sets – A Network Perspective.
Methods Mol Biol. 2015;1243:237-53.

 

Schiffer,E., Vlahou,A., Petrolekas,A., Stravodimos,K., Tauber,R., Geschwend,J.E., Neuhaus,J., Stolzenburg,J.U., Conaway,M.R., Mischak,H., and Theodorescu,D.
Prediction of muscle-invasive bladder cancer using urinary proteomics.
Clin. Cancer Res. 15, 4935-4943.

 


Dakna,M., Harris,K., Kalousis,A., Carpentier,S., Kolch,W., Schanstra,J.P., Haubitz,M., Vlahou,A., Mischak,H., and Girolami,M. (2010).
Addressing the challenge of defining valid proteomic biomarkers and classifiers.
BMC. Bioinformatics. 11, 594.

 


Makridakis,M., Roubelakis,M.G., Bitsika,V., Dimuccio,V., Samiotaki,M., Kossida,S., Panayotou,G., Coleman,J., Candiano,G., Anagnou,N.P., and Vlahou,A. (2010).
Analysis of secreted proteins for the study of bladder cancer cell aggressiveness.
J Proteome Res. 9, 3243-3259.

 


Mischak,H., Allmaier,G., Apweiler,R., Attwood,T., Baumann,M., Benigni,A., Bennett,S.E., Bischoff,R., Bongcam-Rudloff,E., Capasso,G., Coon,J.J., D'Haese,P., Dominiczak,A.F., Dakna,M., Dihazi,H., Ehrich,J.H., Fernandez-Llama,P., Fliser,D., Frokiaer,J., Garin,J., Girolami,M., Hancock,W.S., Haubitz,M., Hochstrasser,D., Holman,R.R., Ioannidis,J.P., Jankowski,J., Julian,B.A., Klein,J.B., Kolch,W., Luider,T., Massy,Z., Mattes,W.B., Molina,F., Monsarrat,B., Novak,J., Peter,K., Rossing,P., Sanchez-Carbayo,M., Schanstra,J.P., Semmes,O.J., Spasovski,G., Theodorescu,D., Thongboonkerd,V., Vanholder,R., Veenstra,T.D., Weissinger,E., Yamamoto,T., and Vlahou,A. (2010).
Recommendations for biomarker identification and qualification in clinical proteomics.
Sci. Transl. Med. 2, 46ps42.

 


Vlahou,A. (2011).
Back to the future in bladder cancer research.
Expert Rev. Proteomics 8, 295-297.

 


Mischak,H., Ioannidis,J.P., Argiles,A., Attwood,T.K., Bongcam-Rudloff,E., Broenstrup,M., Charonis,A., Chrousos,G.P., Delles,C., Dominiczak,A., Dylag,T., Ehrich,J., Egido,J., Findeisen,P., Jankowski,J., Johnson,R.W., Julien,B.A., Lankisch,T., Leung,H.Y., Maahs,D., Magni,F., Manns,M.P., Manolis,E., Mayer,G., Navis,G., Novak,J., Ortiz,A., Persson,F., Peter,K., Riese,H.H., Rossing,P., Sattar,N., Spasovski,G., Thongboonkerd,V., Vanholder,R., Schanstra,J.P., and Vlahou,A. (2012).
Implementation of proteomic biomarkers: making it work.
Eur. J Clin Invest.

 


Zoidakis,J., Makridakis,M., Zerefos,P.G., Bitsika,V., Esteban,S., Frantzi,M., Stravodimos,K., Anagnou,N.P., Roubelakis,M.G., Sanchez-Carbayo,M., and Vlahou,A. (2012).
Profilin 1 is a potential biomarker for bladder cancer aggressiveness.
Mol. Cell Proteomics 11, M111.009449.

 

© Copyright 2017 BcMolMed | Legal Notice